Skip to content

Opening book details…

About this Medicine article

Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non–Small-Cell Lung Cancer (GALAXY-2) by Pillai, Rathi N.; Fennell, Dean A.; Kovcin, Vladimir; Ciuleanu, Tudor-Eliade; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Yalcin, Ilker; Teofilovici, Florentina; Vukovic, Vojo M.; Ramalingam, Suresh S. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Pillai, Rathi N.; Fennell, Dean A.; Kovcin, Vladimir; Ciuleanu, Tudor-Eliade; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Yalcin, Ilker; Teofilovici, Florentina; Vukovic, Vojo M.; Ramalingam, Suresh S.
Publisher
American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)
Published
2019
Field
Medicine (Health Sciences)